MedPath

Study of expenditure on breast cancer treatment in women undergoing treatment at tertiary cancer center

Not Applicable
Conditions
Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Registration Number
CTRI/2019/07/020142
Lead Sponsor
Womens cancer initiative
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Pathologically confirmed new invasive breast cancer cases

2) Non-metastatic invasive breast cancer (AJCC 8th edition)

3) Intending to receive entire treatment at TMC

4) Planned for multi-modality treatment comprising of surgery, chemotherapy and radiotherapy with or without hormone therapy or targeted therapy

5) Age > 18 years

6) Patient willing to provide all estimates of expenditure before and after coming to the tertiary hospital.

7) Patient willing to share relevant socio-demographic information.

8) Willing to fill or respond to QOL instruments.

Exclusion Criteria

1) Unable or unwilling to give written informed consent

2) Inability to follow up after treatment completion.

3) Not willing for follow up till 2 years.

4) Recurrent or progressive disease.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath